ISOFARMICS Trademark Information

Trademark by The Jackson Laboratory

Pharmaceutical preparations and therapeutic vaccines for the treatment of cancer and immune system related diseases

Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology, immunology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, immunology and pharmaceuticals

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: ISOFARMICS
Status/Status Date:
SECOND EXTENSION - GRANTED
6/15/2021
Serial Number: 88791037
Filing Date: 2/10/2020
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparations and therapeutic vaccines for the treatment of cancer and immune system related diseases
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 4/21/2020
Last Applicant/Owner:
The Jackson Laboratory
Bar Harbor, ME 04609
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
WOLF, GREENFIELD & SACKS, P.C.
600 ATLANTIC AVENUE
BOSTON MA 02210
Current Status:
SECOND EXTENSION - GRANTED
6/15/2021
Correspondent Search:
CHRISTINA M. LICURSI is a correspondent of ISOFARMICS trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on